At En Vogue IV Therapy & Wellness, we ensure you understand what to expect throughout your treatment
Some studies have demonstrated an increased risk of depression and anxiety in individuals taking GLP-1s, and, anecdotally, some patients report experiencing emotional numbing when taking GLP-1 medications." And, she warned, the drugs could exacerbate disordered eating for some people
A provider that answers these clearly and specifically is a different proposition from one that deflects
There was no increased risk for hypoglycemia in the lixisenatide group
Weight maintenance during the switch is typical
Overall, current epidemiologic evidence shows that GLP-1RAs consistently induce fat loss accompanied by proportional lean tissue reduction (Table 1)